SGLT2 Inhibitors
Sort by:
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
FEATURING
Silvio Inzucchi
- 39,890 views
- June 16, 2017
- 195
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendations for HFrEF and HFmrEF Treatment
FEATURING
Paul Heidenreich
- 18,896 views
- April 21, 2022
- 59
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
FEATURING
Anastasia Armbruster
- 17,429 views
- March 31, 2023
- 95
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century - Almost
FEATURING
Ralph DeFronzo
- 11,582 views
- August 12, 2019
- 58
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition
FEATURING
Ralph DeFronzo
- 9,424 views
- November 10, 2017
- 64
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
FEATURING
Lance Sloan
- 7,999 views
- June 17, 2019
- 48
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
- 7,985 views
- April 12, 2022
- 52
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
FEATURING
Guillermo Umpierrez
- 3,780 views
- May 15, 2020
- 22
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
FEATURING
Nasrien Ibrahim
- 3,493 views
- April 22, 2022
- 33
13th Orange County Symposium for Cardiovascular Disease Prevention
SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Which Do I Choose?
FEATURING
Yehuda Handelsman
- 3,406 views
- January 27, 2022
- 15
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
- 3,363 views
- August 20, 2018
- 24
Top Ten Topics in Clinical Cardiology 2023
Medical Management of Diastolic Dysfunction: Does The Emperor Finally Have Clothes?
FEATURING
Sean Pinney
- 3,011 views
- November 8, 2023
- 26
Javed Butler
SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus
- 2,918 views
- August 21, 2018
- 22
John Tayek
2020 Updates on Insulin Therapy: What Are the Current ADA Standards of Care?
- 2,466 views
- November 25, 2020
- 13
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 2
FEATURING
Eden Miller
- 2,357 views
- November 30, 2023
- 20
Texas Cardiovascular Innovations Conference 2021
New Heart Failure Treatment Recommendations
FEATURING
Albert Hicks
- 2,272 views
- March 3, 2022
- 14
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Obesity, Diabetes and Cancer Risk
FEATURING
Derek LeRoith
- 2,237 views
- June 16, 2017
- 8
Cleveland Clinic | 12th Annual Obesity Summit
What To Do After Metformin: GLP-1, SGLT2 or DPP-4?
FEATURING
Kevin Pantalone
- 2,114 views
- December 3, 2017
- 5
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?
FEATURING
Barry Greenberg
- 2,010 views
- February 5, 2021
- 22
Inova Cherry Blossom Cardiovascular Symposium 2022
The Dangerous Intersection of Diabetes and Heart (and Kidney) Disease
FEATURING
Darren K. Mcguire
- 1,954 views
- August 2, 2022
- 13
Houston Methodist DeBakey Heart and Vascular Center
Should Cardiometabolic Protective Agents be the First Choice for Diabetic Patients?
FEATURING
Kershaw Patel
- 1,913 views
- November 15, 2022
- 8
ACC 2023 Conference Coverage
ACC 2023: Beyond the Guidelines - Emerging Pharmacologic Therapies for the Heart Failure Treatment
FEATURING
Freny Mody
- 1,868 views
- April 25, 2023
- 12